Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Post by canadafanon May 19, 2020 2:54am
450 Views
Post# 31044386

Time to move forward...Another great day all

Time to move forward...Another great day allTime to leave the name calling and bickering behind.
ONCY on the NAS closed after a 30% increase & followed that with 121,000 shares on the after market , up another 5%+

Unless there is a massive sell off, that equates to very close to $4.00 CDN , as an open.
We saw similar typ eof activity just before the end of 2019, when the price went into a pleaseant but unussual rise to close to $6 CDN.
I have no idea what is going on, but expect we will know soon.
Could even be just general market activity. 
Many of the pharma compaines were up Monday on the NAS & the whole market was up, so could be that?
Either way, dont care, always good to see.
Wishing everyone a safe, healthy & prosperous trading week.
BTW, I had my surgery last Friday. no Canacer and the proceedure has improved my quality of life..amazingly.
I could be around for many more years to come. it might take that long for ONC to get bought, but ill be here.........
Again, all the best.


Bullboard Posts